NCT05550467
- Conditions
- Chronic Disease, Chronic Kidney Diseases, Disease Attributes, +11 more
- Locations
-
Not specified
Clinical trial condition
Urologic Diseases
Explore clinical trials studying Urologic Diseases. Study availability and eligibility vary by location and protocol.
13,901 public trials
2,181 recruiting studies
Urologic Diseases trial results
NCT04206085
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +10 more
- Locations
-
- Milestone Research London, Ontario, Canada
- Bluewater Clinical Research Group Sarnia, Ontario, Canada
- Devonshire Clinical Research Woodstock, Ontario, Canada
NCT01652872
- Conditions
- Anemia, Anemia in Chronic Kidney Disease Patients Not on Dialysis, Chronic Disease, +13 more
- Locations
-
- Research Site Anniston, Alabama, United States
- Research Site Birmingham, Alabama, United States
- Research Site Huntsville, Alabama, United States
- Research Site Mobile, Alabama, United States
Completed
LIBERATE International
NCT03619174
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Infections, +12 more
- Locations
-
- LIBERATE In't Site Vancouver, British Columbia, Canada
- LIBERATE Int'l Site Pointe-Claire, Montreal, Canada
- LIBERATE Int'l Site Burlington, Ontario, Canada
- LIBERATE Int'l Site London, Ontario, Canada
Completed
Vaginal Estriol in Multiple Sclerosis
NCT03774407
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +15 more
- Locations
-
- Texas Tech University Health Sciences Center Lubbock, Texas, United States
NCT03806530
- Conditions
- Chronic Disease, Disease Attributes, Dyssomnias, +18 more
- Locations
-
- Nova Scotia Health Authority Halifax, Nova Scotia, Canada
- St. Joseph's Hamilton Healthcare Hamilton, Ontario, Canada
- The Ottawa Hospital Ottawa, Ontario, Canada
NCT04810598
- Conditions
- Chronic Disease, Disease Attributes, Female Urogenital Diseases, +12 more
- Locations
-
- Orlando Clinical Research Ctr /ID# 224922 Orlando, Florida, United States
- Acpru /Id# 243398 Grayslake, Illinois, United States
Completed
A Phase 2b Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer
NCT03558503
- Conditions
- Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +16 more
- Locations
-
- Mayo Clinic Cancer Center Phoenix, Arizona, United States
- Arkansas Urology Little Rock, Arkansas, United States
- Loma Linda University Loma Linda, California, United States
- Providence Medical Institute Santa Monica, California, United States
NCT04651244
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hydronephrosis, +5 more
- Locations
-
- Hospital of Southern Jutland Aabenraa, Denmark
Completed
CB-839 With Everolimus vs. Placebo With Everolimus in Participants With Renal Cell Carcinoma (RCC)
NCT03163667
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- The University of Arizona Cancer Center Tucson, Arizona, United States
- Highlands Oncology Group Rogers, Arkansas, United States
- Los Angeles Hematology Oncology Medical Group Los Angeles, California, United States
- UCLA Department of Medicine - Hematology/Oncology Los Angeles, California, United States